News
-
-
REGULATED PRESS RELEASE
Gimv increases its stake in TINC – Gimv and Belfius conclude agreement in principle on the sale of the shares of Belfius Insurance in TINC
Gimv increases stake in TINC as Gimv and Belfius agree on share sale deal. Newly created company with Gimv as majority shareholder to ensure stability of TINC's shareholdership -
REGULATED PRESS RELEASE
Gimv versterkt zijn participatie in TINC - Gimv en Belfius sluiten principe-akkoord over de verkoop van de TINC-aandelen van Belfius Insurance
Gimv versterkt participatie in TINC door overname Belfius-aandelen. Nieuwe vennootschap met Gimv als meerderheidsaandeelhouder. Stabiliteit aandeelhouderschap TINC bestendigd -
REGULATED PRESS RELEASE
Gimv increases its stake in TINC – Gimv and Belfius conclude agreement in principle on the sale of the shares of Belfius Insurance in TINC
Gimv increases stake in TINC as Gimv and Belfius agree on sale of Belfius Insurance shares, ensuring stability. Newly created company with Gimv as majority shareholder to acquire shares from Belfius Insurance at 11.77 euros per share -
-
PRESS RELEASE
HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
HORNBACH Group reports 44% y-o-y increase in earnings per share for Q1 2024/25. Full-year outlook remains unchanged. Solid results driven by normalized gross margin and cost discipline -
PRESS RELEASE
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
Kuros Biosciences announces the publication of MagnetOs MAXA Level 1 study outcomes in Spine, showing superiority over autograft. Study details effectiveness of MagnetOs in posterolateral fusions -
-
-
